A股異動 | 精測電子(300567.SZ)漲超4% 擬收購參股公司武漢頤光剩餘股權
格隆匯6月22日丨精測電子(300567.SZ)現報72.21元,漲4.12%,暫成交9億元,最新總市值177億元。精測電子昨日(21日)晚間發公告稱,公司控股子公司上海精測擬以4920萬元,購買參股公司武漢頤光科技有限公司(簡稱“武漢頤光”)剩餘82%的股權。交易完成後,上海精測將持有武漢頤光100%股權。收購參股公司股權將有利於加快推進公司在高端光譜橢偏儀領域產業的佈局和取得市場份額,進一步完善公司在半導體行業全產業鏈的業務佈局。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.